Location: Boston, MA
CIK: 0001816307 · Show all filings
Period: Q2 2023 (← Previous) (Next →)
Filing Date: Aug 14, 2023
Total Value: $323M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ImmunoGen Inc | 1,420,000 | $26.8M | 8.3% | $17.62 | — | EQUITIES | 45253H101 |
| — | Merus NV | 589,255 | $15.52M | 4.8% | $19.70 | — | EQUITIES | N5749R100 |
| — | Morphic Holding Inc | 252,309 | $14.46M | 4.5% | $50.86 | — | EQUITIES | 61775R105 |
| SDGR | Schrodinger Inc | 286,169 | $14.29M | 4.4% | $25.19 | +34.2% | EQUITIES | 80810D103 |
| KRYS | Krystal Biotech Inc | 118,941 | $13.96M | 4.3% | $90.31 | +13.1% | EQUITIES | 501147102 |
| — | Intra-Cellular Therapies Inc | 198,723 | $12.58M | 3.9% | $54.36 | — | EQUITIES | 46116X101 |
| — | Akero Therapeutics Inc | 241,357 | $11.27M | 3.5% | $21.39 | — | EQUITIES | 00973Y108 |
| ORIC | Oric Pharmaceuticals Inc | 1,450,822 | $11.26M | 3.5% | $4.17 | +36.3% | EQUITIES | 68622P109 |
| — | Akero Therapeutics Inc | 236,500 | $11.04M | 3.4% | $21.39 | — | Call | 00973Y108 |
| MLTX | MoonLake Immunotherapeutics | 200,000 | $10.2M | 3.2% | $21.57 | +24.7% | EQUITIES | 61559X104 |
| BIIB | Biogen Idec Inc | 26,854 | $7.649M | 2.4% | $291.36 | +2.2% | EQUITIES | 09062X103 |
| — | 89bio Inc | 396,497 | $7.514M | 2.3% | $15.23 | — | EQUITIES | 282559103 |
| COGT | Cogent Biosciences Inc | 620,000 | $7.341M | 2.3% | $11.30 | +1.5% | EQUITIES | 19240Q201 |
| ACRS | Aclaris Therapeutics Inc | 651,400 | $6.755M | 2.1% | $15.96 | -43.3% | Call | 00461U105 |
| UTHR | United Therapeutics Corp | 30,029 | $6.629M | 2.1% | $214.25 | +3.4% | EQUITIES | 91307C102 |
| MGNX | MacroGenics Inc | 1,215,675 | $6.504M | 2.0% | $5.66 | +9.0% | EQUITIES | 556099109 |
| KALV | KalVista Pharmaceuticals Inc | 720,508 | $6.485M | 2.0% | $7.46 | +23.6% | EQUITIES | 483497103 |
| VCYT | Veracyte Inc | 229,451 | $5.844M | 1.8% | $30.03 | -19.3% | EQUITIES | 92337F107 |
| — | Mirati Therapeutics Inc | 150,000 | $5.42M | 1.7% | $36.13 | — | Call | 60468T105 |
| BCRX | BioCryst Pharmaceuticals Inc | 760,904 | $5.357M | 1.7% | $10.58 | -24.1% | EQUITIES | 09058V103 |
| TERN | Terns Pharmaceuticals Inc | 599,668 | $5.247M | 1.6% | $6.60 | +76.7% | EQUITIES | 880881107 |
| — | Poseida Therapeutics Inc | 2,945,948 | $5.185M | 1.6% | $3.50 | — | EQUITIES | 73730P108 |
| NUVL | Nuvalent Inc | 115,067 | $4.852M | 1.5% | $26.36 | +43.4% | EQUITIES | 670703107 |
| GILD | Gilead Sciences Inc | 60,448 | $4.659M | 1.4% | $71.32 | +1.8% | EQUITIES | 375558103 |
| VRTX | Vertex Pharmaceuticals Inc | 13,175 | $4.636M | 1.4% | $240.06 | +40.4% | EQUITIES | 92532F100 |
| TELA | Tela Bio Inc | 416,440 | $4.219M | 1.3% | $10.33 | -1.0% | EQUITIES | 872381108 |
| VKTX | Viking Therapeutics Inc | 258,595 | $4.192M | 1.3% | $10.33 | +102.8% | EQUITIES | 92686J106 |
| — | Praxis Precision Medicines Inc | 3,476,162 | $3.998M | 1.2% | $1.15 | — | EQUITIES | 74006W108 |
| XENE | Xenon Pharmaceuticals Inc | 99,756 | $3.841M | 1.2% | $29.94 | +32.7% | EQUITIES | 98420N105 |
| — | Mersana Therapeutics Inc | 1,100,000 | $3.619M | 1.1% | $4.24 | — | Call | 59045L106 |
| OLMA | Olema Pharmaceuticals Inc | 390,466 | $3.526M | 1.1% | $6.04 | 0.0% | EQUITIES | 68062P106 |
| SRPT | Sarepta Therapeutics Inc | 29,860 | $3.42M | 1.1% | $129.09 | -0.2% | EQUITIES | 803607100 |
| PRTA | Prothena Corporation PLC | 49,721 | $3.395M | 1.1% | $64.50 | 0.0% | EQUITIES | G72800108 |
| — | Mirati Therapeutics Inc | 91,213 | $3.296M | 1.0% | $36.13 | — | EQUITIES | 60468T105 |
| — | Mersana Therapeutics Inc | 1,000,000 | $3.29M | 1.0% | $4.24 | — | EQUITIES | 59045L106 |
| INSM | Insmed Inc | 144,464 | $3.048M | 0.9% | $27.01 | -29.7% | EQUITIES | 457669307 |
| PHVS | Pharvaris NV | 200,000 | $3.028M | 0.9% | $8.17 | +17.8% | EQUITIES | N69605108 |
| ANIP | ANI Pharmaceuticals Inc | 54,041 | $2.909M | 0.9% | $44.33 | 0.0% | EQUITIES | 00182C103 |
| PHAT | Phathom Pharmaceuticals Inc | 200,000 | $2.864M | 0.9% | $8.78 | +31.3% | EQUITIES | 71722W107 |
| CERS | Cerus Corp | 1,158,265 | $2.849M | 0.9% | $5.67 | -58.1% | EQUITIES | 157085101 |
| MIRM | Mirum Pharmaceuticals Inc | 106,375 | $2.752M | 0.9% | $22.79 | +16.7% | EQUITIES | 604749101 |
| ACRS | Aclaris Therapeutics Inc | 219,229 | $2.273M | 0.7% | $15.96 | -43.3% | EQUITIES | 00461U105 |
| INCY | Incyte Corp | 34,110 | $2.123M | 0.7% | $78.23 | -14.6% | EQUITIES | 45337C102 |
| TRVI | Trevi Therapeutics Inc | 885,924 | $2.117M | 0.7% | $3.14 | -19.8% | EQUITIES | 89532M101 |
| NTLA | Intellia Therapeutics Inc | 50,858 | $2.074M | 0.6% | $54.04 | -25.0% | EQUITIES | 45826J105 |
| PLRX | Pliant Therapeutics Inc | 107,267 | $1.944M | 0.6% | $19.50 | +21.4% | EQUITIES | 729139105 |
| RYTM | Rhythm Pharmaceuticals Inc | 116,168 | $1.916M | 0.6% | $18.05 | 0.0% | EQUITIES | 76243J105 |
| — | CymaBay Therapeutics Inc | 160,000 | $1.752M | 0.5% | $10.95 | — | EQUITIES | 23257D103 |
| — | Ambrx Biopharma Inc | 100,000 | $1.646M | 0.5% | $16.46 | — | EQUITIES | 02290A102 |
| CUE | Cue Biopharma Inc | 403,402 | $1.472M | 0.5% | $3.26 | +20.2% | EQUITIES | 22978P106 |
| CLYM | Eliem Therapeutics Inc | 494,089 | $1.383M | 0.4% | $4.94 | -38.5% | EQUITIES | 28658R106 |
| ANNX | Annexon Inc | 389,911 | $1.372M | 0.4% | $4.37 | 0.0% | EQUITIES | 03589W102 |
| ZURA | Zura Bio Ltd | 160,000 | $1.312M | 0.4% | $8.03 | 0.0% | EQUITIES | G9TY5A101 |
| — | Reata Pharmaceuticals Inc | 12,500 | $1.274M | 0.4% | $101.96 | — | EQUITIES | 75615P103 |
| ALKS | Alkermes Plc | 40,000 | $1.252M | 0.4% | $30.28 | 0.0% | EQUITIES | G01767105 |
| VYGR | Voyager Therapeutics Inc | 100,000 | $1.145M | 0.4% | $11.45 | — | EQUITIES | 92915B106 |
| VRDN | Viridian Therapeutics Inc | 45,000 | $1.071M | 0.3% | $30.23 | -15.2% | EQUITIES | 92790C104 |
| RZLT | Rezolute Inc | 499,544 | $989K | 0.3% | $2.06 | 0.0% | EQUITIES | 76200L309 |
| — | Karyopharm Therapeutics Inc | 518,985 | $929K | 0.3% | $3.89 | — | EQUITIES | 48576U106 |
| — | Allakos Inc | 200,000 | $872K | 0.3% | $6.51 | — | EQUITIES | 01671P100 |
| BMRN | BioMarin Pharmaceutical Inc | 10,000 | $867K | 0.3% | $94.11 | 0.0% | EQUITIES | 09061G101 |
| BBIO | Bridgebio Pharma Inc | 50,000 | $860K | 0.3% | $12.34 | +22.0% | EQUITIES | 10806X102 |
| — | Point Biopharma Global Inc | 93,700 | $849K | 0.3% | $7.62 | — | EQUITIES | 730541109 |
| VTYX | Ventyx Biosciences Inc | 25,000 | $820K | 0.3% | $38.88 | -11.3% | EQUITIES | 92332V107 |
| PTGX | Protagonist Therapeutics Inc | 25,000 | $691K | 0.2% | $16.79 | +49.0% | EQUITIES | 74366E102 |
| — | Jasper Therapeutics Inc | 500,000 | $685K | 0.2% | $1.81 | — | EQUITIES | 471871103 |
| — | Aligos Therapeutics Inc | 631,887 | $614K | 0.2% | $0.87 | — | EQUITIES | 01626L105 |
| BHVN | Biohaven Ltd | 20,000 | $478K | 0.1% | $17.21 | 0.0% | EQUITIES | G1110E107 |
| SNDX | Syndax Pharmaceuticals Inc | 20,000 | $419K | 0.1% | $20.82 | 0.0% | EQUITIES | 87164F105 |
| CGEN | Compugen Ltd | 330,188 | $376K | 0.1% | $0.87 | -0.1% | EQUITIES | M25722105 |
| IMTX | Immatics Nv | 30,715 | $354K | 0.1% | $10.84 | -13.9% | EQUITIES | N44445109 |
| CLDX | Celldex Therapeutics Inc | 10,000 | $339K | 0.1% | $40.09 | -15.9% | EQUITIES | 15117B202 |
| — | FibroGen Inc | 100,000 | $271K | 0.1% | — | — | Call | 31572Q808 |
| — | Clene Inc | 250,000 | $220K | 0.1% | $0.88 | — | EQUITIES | 185634102 |
| GLUE | Monte Rosa Therapeutics Inc | 31,156 | $213K | 0.1% | $6.95 | -7.0% | EQUITIES | 61225M102 |
| ELOX | Eloxx Pharmaceuticals Inc | 54,075 | $210K | 0.1% | $4.22 | +51.8% | EQUITIES | 29014R202 |
| — | Pieris Pharmaceuticals Inc | 961,338 | $159K | 0.0% | $0.17 | — | EQUITIES | 720795103 |
| — | Evogene Ltd | 100,000 | $107K | 0.0% | $1.07 | — | EQUITIES | M4119S104 |
| GKOS | Glaukos Corp | 1,000 | $71,210 | 0.0% | $57.41 | 0.0% | EQUITIES | 377322102 |
| VRAYQ | Viewray Inc | 100,000 | $35,220 | 0.0% | $3.87 | -73.2% | EQUITIES | 92672L107 |
| RCKTW | Rocket Pharmaceuticals Inc | 104,828 | $19,917 | 0.0% | $0.11 | — | WARRANTS | 77313F114 |
| — | Fresh Tracks Therapeutics Inc | 10,000 | $7,013 | 0.0% | $1.50 | — | EQUITIES | 10802T204 |